What is the current annual EBITDA of ICLR?

As of today, ICLR annual EBITDA is $1.47B

What is 1-year change in ICLR annual EBITDA?

ICLR annual EBITDA is down -12.57% year-over-year

What is 3-year change in ICLR annual EBITDA?

ICLR annual EBITDA is up +1.10% over the past 3 years

How far is ICLR annual EBITDA from its all-time high?

ICLR annual EBITDA is currently -12.77% below its historical high of $1.69B set on December 31, 2023

How does ICLR annual EBITDA rank versus sector peers?

ICLR annual EBITDA is higher than 94.35% of companies in Healthcare sector

When is ICLR next annual earnings release?

As of today, the next annual earnings release for ICLR has not been scheduled

What is the current quarterly EBITDA of ICLR?

As of today, ICLR quarterly EBITDA is $286.31M

What is ICLR quarterly EBITDA most recent change?

ICLR quarterly EBITDA was down -6.95% on March 31, 2026

What is 1-year change in ICLR quarterly EBITDA?

ICLR quarterly EBITDA is down -22.55% year-over-year

How far is ICLR quarterly EBITDA from its all-time high?

ICLR quarterly EBITDA is currently -41.72% below its historical high of $491.26M set on December 31, 2024

How does ICLR quarterly EBITDA rank versus sector peers?

ICLR quarterly EBITDA is higher than 93.18% of companies in Healthcare sector

When is ICLR next earnings release?

The next earnings release for ICLR is on July 23, 2026

What is the current TTM EBITDA of ICLR?

As of today, ICLR TTM EBITDA is $1.34B

What is ICLR TTM EBITDA most recent change?

ICLR TTM EBITDA was down -5.85% on March 31, 2026

What is 1-year change in ICLR TTM EBITDA?

ICLR TTM EBITDA is down -18.34% year-over-year

How far is ICLR TTM EBITDA from its all-time high?

ICLR TTM EBITDA is currently -20.61% below its historical high of $1.69B set on March 31, 2024

How does ICLR TTM EBITDA rank versus sector peers?

ICLR TTM EBITDA is higher than 93.74% of companies in Healthcare sector

When is ICLR next earnings release?

The next earnings release for ICLR is on July 23, 2026

ICLR EBITDA History & Chart Since 1997

Annual EBITDA

$1.47B$211.50M-12.57%

December 31, 2025

Summary

Current Value: As of today, ICLR annual EBITDA is $1.47B, down -12.57% on December 31, 2025
Historical Performance: ICLR annual EBITDA is up +1.10% over the past 3 years, up +188.31% over the past 5 years
All-Time High Comparison: ICLR annual EBITDA is currently -12.77% below its historical high of $1.69B set on December 31, 2023
3-Year Low Comparison: ICLR annual EBITDA is +1.10% above its 3-year low of $1.45B reached on an earlier date
Sector Comparison: ICLR annual EBITDA is higher than 94.35% of companies in Healthcare sector

EBITDA Chart

Performance

ICLR Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$1.47B	-12.6%	+1.1%	+188.3%	+1067.7%
Quarterly EBITDA	Mar 31, 26	$286.31M	-22.6%	-27.4%	+103.7%	+1047.8%
TTM EBITDA	Mar 31, 26	$1.34B	-18.3%	-11.3%	+160.5%	+1061.8%
Price	Jul 9, 26	$168.77	+12.1%	-28.6%	-19.8%	+569.5%
PE Ratio	Jul 9, 26	77.73	+447.4%	+103.1%	+152.1%	+220.7%
Annual Revenue	Dec 31, 25	$8.25B	+0.8%	+6.6%	+195.0%	+816.8%
Annual EPS	Dec 31, 25	$2.90	-67.4%	-52.6%	-53.4%	+101.7%
	Dec 31, 25	$1.05B	-8.9%	+25.2%	+153.1%	+1042.0%
Annual Net Income	Dec 31, 25	$229.34M	-69.0%	-54.6%	-31.1%	+163.4%

EBITDA Highs

ICLR Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.69B	Dec 31, 23	-12.8%
5Y	$1.69B	Dec 31, 23	-12.8%
All	$1.69B	Dec 31, 23	-12.8%

EBITDA Lows

ICLR Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$1.45B	N/A	+1.1%
5Y	$510.17M	N/A	+188.3%
All	$8.74M	May 31, 98	>+9999.0%

EBITDA History

Year	Value	Change
2025	$1.47B	-12.6%
2024	$1.68B	-0.2%
2023	$1.69B	+15.9%
2022	$1.45B	+52.5%
2021	$953.91M	+87.0%
2020	$510.17M	-3.0%
2019	$525.92M	+17.4%
2018	$447.89M	+9.5%
2017	$409.10M	+7.2%
2016	$381.52M	+13.7%
2015	$335.61M	+30.2%
2014	$257.75M	+46.9%
2013	$175.48M	+52.3%
2012	$115.25M	+47.9%

Year	Value	Change
2011	$77.94M	-38.1%
2010	$125.97M	-15.4%
2009	$148.92M	+19.3%
2008	$124.85M	+32.1%
2007	$94.52M	+47.0%
2006	$64.30M	+90.9%
2005	$33.68M	-26.1%
2004	$45.55M	+33.2%
2003	$34.20M	+41.1%
2002	$24.23M	+51.0%
2001	$16.05M	+64.5%
2000	$9.76M	-10.1%
1999	$10.86M	+24.2%
1998	$8.74M	-

FAQ

What is the current annual EBITDA of ICLR?
As of today, ICLR annual EBITDA is $1.47B
What is 1-year change in ICLR annual EBITDA?
ICLR annual EBITDA is down -12.57% year-over-year
What is 3-year change in ICLR annual EBITDA?
ICLR annual EBITDA is up +1.10% over the past 3 years
How far is ICLR annual EBITDA from its all-time high?
ICLR annual EBITDA is currently -12.77% below its historical high of $1.69B set on December 31, 2023
How does ICLR annual EBITDA rank versus sector peers?
ICLR annual EBITDA is higher than 94.35% of companies in Healthcare sector
When is ICLR next annual earnings release?
As of today, the next annual earnings release for ICLR has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$286.31M$21.37M-6.95%

March 31, 2026

Summary

Current Value: As of today, ICLR quarterly EBITDA is $286.31M, down -6.95% on March 31, 2026
Historical Performance: ICLR quarterly EBITDA is down -22.55% year-over-year, down -27.39% over the past 3 years
All-Time High Comparison: ICLR quarterly EBITDA is currently -41.72% below its historical high of $491.26M set on December 31, 2024
3-Year Low Comparison: ICLR quarterly EBITDA is at its 3-year low
Sector Comparison: ICLR quarterly EBITDA is higher than 93.18% of companies in Healthcare sector

Performance

ICLR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Mar 31, 26	$286.31M	-7.0%	-22.6%	-27.4%	+103.7%
Annual EBITDA	Dec 31, 25	$1.47B	–	-12.6%	+1.1%	+188.3%
TTM EBITDA	Mar 31, 26	$1.34B	-5.8%	-18.3%	-11.3%	+160.5%
Price	Jul 9, 26	$168.77	+58.2%	+12.1%	-28.6%	-19.8%
PE Ratio	Jul 9, 26	77.73	+58.2%	+447.4%	+103.1%	+152.1%
Quarterly Revenue	Mar 31, 26	$2.03B	-3.7%	+1.6%	+2.8%	+137.0%
Quarterly EPS	Mar 31, 26	$1.36	-29.8%	-28.8%	-4.0%	-25.6%
	Mar 31, 26	$187.00M	-11.3%	-29.3%	-21.4%	+61.2%
Quarterly Net Income	Mar 31, 26	$104.75M	-29.8%	-32.0%	-10.2%	+7.9%

Quarterly EBITDA Highs

ICLR Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$387.92M	N/A	-26.2%
3Y	$491.26M	Dec 31, 24	-41.7%
5Y	$491.26M	Dec 31, 24	-41.7%
All	$491.26M	Dec 31, 24	-41.7%

Quarterly EBITDA Lows

ICLR Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$286.31M	Mar 31, 26	at low
3Y	$286.31M	Mar 31, 26	at low
5Y	$137.07M	N/A	+108.9%
All	-$34.32M	May 31, 99	+934.2%

Quarterly EBITDA History

Month	Value	Change
Mar 2026	$286.31M	-6.9%
Dec 2025	$307.68M	-14.3%
Sep 2025	$358.91M	-7.5%
Jun 2025	$387.92M	+4.9%
Mar 2025	$369.65M	-24.8%
Dec 2024	$491.26M	+18.7%
Sep 2024	$413.91M	+12.7%
Jun 2024	$367.11M	-10.5%
Mar 2024	$410.09M	-5.2%
Dec 2023	$432.53M	+0.3%
Sep 2023	$431.15M	+3.8%
Jun 2023	$415.21M	+5.3%
Mar 2023	$394.33M	+8.2%
Dec 2022	$364.55M	-8.8%
Sep 2022	$399.80M	+13.2%
Jun 2022	$353.18M	+7.7%
Mar 2022	$328.04M	-3.5%
Dec 2021	$339.83M	+6.8%
Sep 2021	$318.27M	+132.2%
Jun 2021	$137.07M	-2.5%
Mar 2021	$140.53M	-2.5%
Dec 2020	$144.12M	+9.0%
Sep 2020	$132.23M	+35.1%
Jun 2020	$97.91M	-24.7%
Mar 2020	$129.94M	-6.2%
Dec 2019	$138.54M	+4.1%
Sep 2019	$133.02M	+3.2%
Jun 2019	$128.88M	+3.2%
Mar 2019	$124.89M	+7.0%
Dec 2018	$116.70M	+1.5%
Sep 2018	$115.00M	+3.2%
Jun 2018	$111.45M	+2.6%
Mar 2018	$108.62M	+2.6%
Dec 2017	$105.91M	+4.6%
Sep 2017	$101.21M	+7.5%
Jun 2017	$94.14M	-6.0%
Mar 2017	$100.10M	-0.0%
Dec 2016	$100.10M	+4.6%
Sep 2016	$95.72M	+3.5%
Jun 2016	$92.48M	+1.5%
Mar 2016	$91.13M	+0.7%
Dec 2015	$90.49M	+5.5%
Sep 2015	$85.75M	+4.1%
Jun 2015	$82.38M	+2.2%
Mar 2015	$80.60M	+7.8%
Dec 2014	$74.77M	+2.2%
Sep 2014	$73.16M	+19.5%
Jun 2014	$61.21M	+12.2%
Mar 2014	$54.55M	+7.6%
Dec 2013	$50.67M	+13.3%
Sep 2013	$44.74M	+5.4%
Jun 2013	$42.44M	+9.2%
Mar 2013	$38.86M	+11.1%
Dec 2012	$34.99M	+11.2%
Sep 2012	$31.48M	+14.6%
Jun 2012	$27.47M	+21.9%

Month	Value	Change
Mar 2012	$22.53M	+29.8%
Dec 2011	$17.36M	+60.8%
Sep 2011	$10.80M	-56.5%
Jun 2011	$24.84M	-0.4%
Mar 2011	$24.94M	-19.2%
Dec 2010	$30.88M	+20.5%
Sep 2010	$25.63M	-24.5%
Jun 2010	$33.96M	-4.3%
Mar 2010	$35.50M	-9.0%
Dec 2009	$38.99M	+0.5%
Sep 2009	$38.81M	+10.4%
Jun 2009	$35.15M	+0.7%
Mar 2009	$34.91M	+4.1%
Dec 2008	$33.52M	-4.4%
Sep 2008	$35.07M	+13.0%
Jun 2008	$31.04M	+12.4%
Mar 2008	$27.61M	+9.7%
Dec 2007	$25.17M	+6.1%
Sep 2007	$23.72M	+15.7%
Jun 2007	$20.51M	+8.8%
Mar 2007	$18.85M	+6.2%
Dec 2006	$17.74M	+7.6%
Sep 2006	$16.49M	+51.2%
May 2005	$10.90M	+701.2%
Feb 2005	-$1.81M	-117.6%
Nov 2004	$10.30M	-17.9%
Aug 2004	$12.55M	+44.5%
May 2004	$8.68M	-25.5%
Feb 2004	$11.65M	+5.0%
Nov 2003	$11.10M	+8.7%
Aug 2003	$10.21M	+41.4%
May 2003	$7.22M	-10.4%
Feb 2003	$8.06M	+2.3%
Nov 2002	$7.87M	+15.9%
Aug 2002	$6.79M	-34.6%
May 2002	$10.39M	+68.2%
Feb 2002	$6.18M	-16.6%
Nov 2001	$7.41M	+33.5%
Aug 2001	$5.55M	-7.2%
May 2001	$5.98M	+15.7%
Feb 2001	$5.17M	+8.5%
Nov 2000	$4.77M	+6.9%
Aug 2000	$4.46M	+34.2%
May 2000	$3.32M	+5.2%
Feb 2000	$3.16M	+20.9%
Nov 1999	$2.61M	+16.5%
Aug 1999	$2.24M	+106.5%
May 1999	-$34.32M	-333.5%
Feb 1999	$14.70M	+7.3%
Nov 1998	$13.70M	+7.0%
Aug 1998	$12.80M	+5.8%
May 1998	$12.10M	+21.0%
Feb 1998	$10.00M	0.0%
Nov 1997	$10.00M	0.0%
Aug 1997	$10.00M	-

FAQ

What is the current quarterly EBITDA of ICLR?
As of today, ICLR quarterly EBITDA is $286.31M
What is ICLR quarterly EBITDA most recent change?
ICLR quarterly EBITDA was down -6.95% on March 31, 2026
What is 1-year change in ICLR quarterly EBITDA?
ICLR quarterly EBITDA is down -22.55% year-over-year
How far is ICLR quarterly EBITDA from its all-time high?
ICLR quarterly EBITDA is currently -41.72% below its historical high of $491.26M set on December 31, 2024
How does ICLR quarterly EBITDA rank versus sector peers?
ICLR quarterly EBITDA is higher than 93.18% of companies in Healthcare sector
When is ICLR next earnings release?
The next earnings release for ICLR is on July 23, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.34B$83.35M-5.85%

March 31, 2026

Summary

Current Value: As of today, ICLR TTM EBITDA is $1.34B, down -5.85% on March 31, 2026
Historical Performance: ICLR TTM EBITDA is down -18.34% year-over-year, down -11.31% over the past 3 years
All-Time High Comparison: ICLR TTM EBITDA is currently -20.61% below its historical high of $1.69B set on March 31, 2024
3-Year Low Comparison: ICLR TTM EBITDA is at its 3-year low
Sector Comparison: ICLR TTM EBITDA is higher than 93.74% of companies in Healthcare sector

Performance

ICLR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Mar 31, 26	$1.34B	-5.8%	-18.3%	-11.3%	+160.5%
Annual EBITDA	Dec 31, 25	$1.47B	–	-12.6%	+1.1%	+188.3%
Quarterly EBITDA	Mar 31, 26	$286.31M	-7.0%	-22.6%	-27.4%	+103.7%
Price	Jul 9, 26	$168.77	+58.2%	+12.1%	-28.6%	-19.8%
PE Ratio	Jul 9, 26	77.73	+58.2%	+447.4%	+103.1%	+152.1%
TTM Revenue	Mar 31, 26	$8.27B	+0.4%	+1.5%	+5.8%	+181.3%
TTM EPS	Mar 31, 26	$2.17	-20.2%	-76.0%	-64.9%	-65.8%
	Mar 31, 26	$927.74M	-7.7%	-20.6%	+1.1%	+121.3%
TTM Net Income	Mar 31, 26	$173.28M	-22.2%	-76.7%	-66.0%	-48.7%

TTM EBITDA Highs

ICLR TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.66B	N/A	-19.4%
3Y	$1.69B	Mar 31, 24	-20.6%
5Y	$1.69B	Mar 31, 24	-20.6%
All	$1.69B	Mar 31, 24	-20.6%

TTM EBITDA Lows

ICLR TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.34B	Mar 31, 26	at low
3Y	$1.34B	Mar 31, 26	at low
5Y	$553.95M	N/A	+142.1%
All	-$26.31M	Feb 29, 00	+5196.6%

TTM EBITDA History

Month	Value	Change
Mar 2026	$1.34B	-5.9%
Dec 2025	$1.42B	-11.4%
Sep 2025	$1.61B	-3.3%
Jun 2025	$1.66B	+1.3%
Mar 2025	$1.64B	-2.4%
Dec 2024	$1.68B	+3.6%
Sep 2024	$1.62B	-1.1%
Jun 2024	$1.64B	-2.8%
Mar 2024	$1.69B	+0.9%
Dec 2023	$1.67B	+4.2%
Sep 2023	$1.61B	+2.0%
Jun 2023	$1.57B	+4.1%
Mar 2023	$1.51B	+4.6%
Dec 2022	$1.45B	+1.7%
Sep 2022	$1.42B	+6.1%
Jun 2022	$1.34B	+19.2%
Mar 2022	$1.12B	+20.0%
Dec 2021	$935.71M	+26.4%
Sep 2021	$739.99M	+33.6%
Jun 2021	$553.95M	+7.6%
Mar 2021	$514.79M	+2.1%
Dec 2020	$504.20M	+1.1%
Sep 2020	$498.62M	-0.2%
Jun 2020	$499.41M	-5.8%
Mar 2020	$530.38M	+1.0%
Dec 2019	$525.33M	+4.3%
Sep 2019	$503.48M	+3.7%
Jun 2019	$485.46M	+3.7%
Mar 2019	$468.03M	+3.6%
Dec 2018	$451.76M	+2.4%
Sep 2018	$440.98M	+3.2%
Jun 2018	$427.18M	+4.2%
Mar 2018	$409.87M	+2.1%
Dec 2017	$401.34M	+1.5%
Sep 2017	$395.54M	+1.4%
Jun 2017	$390.05M	+0.4%
Mar 2017	$388.39M	+2.4%
Dec 2016	$379.43M	+2.6%
Sep 2016	$369.82M	+2.8%
Jun 2016	$359.85M	+2.9%
Mar 2016	$349.74M	+3.1%
Dec 2015	$339.21M	+4.9%
Sep 2015	$323.50M	+4.0%
Jun 2015	$310.91M	+7.3%
Mar 2015	$289.74M	+9.9%
Dec 2014	$263.69M	+10.1%
Sep 2014	$239.59M	+13.5%
Jun 2014	$211.17M	+9.8%
Mar 2014	$192.40M	+8.9%
Dec 2013	$176.71M	+9.7%
Sep 2013	$161.03M	+9.0%
Jun 2013	$147.78M	+11.3%
Mar 2013	$132.81M	+14.0%
Dec 2012	$116.48M	+17.8%
Sep 2012	$98.85M	+26.5%
Jun 2012	$78.17M	+3.5%

Month	Value	Change
Mar 2012	$75.53M	-3.1%
Dec 2011	$77.94M	-14.8%
Sep 2011	$91.46M	-13.9%
Jun 2011	$106.29M	-7.9%
Mar 2011	$115.41M	-8.4%
Dec 2010	$125.97M	-6.0%
Sep 2010	$134.08M	-9.0%
Jun 2010	$147.26M	-0.8%
Mar 2010	$148.45M	+0.4%
Dec 2009	$147.85M	+3.8%
Sep 2009	$142.38M	+2.7%
Jun 2009	$138.64M	+3.1%
Mar 2009	$134.53M	+5.7%
Dec 2008	$127.23M	+7.0%
Sep 2008	$118.88M	+10.6%
Jun 2008	$107.54M	+10.8%
Mar 2008	$97.01M	+9.9%
Dec 2007	$88.25M	+9.2%
Sep 2007	$80.82M	+9.8%
Jun 2007	$73.59M	+38.6%
Mar 2007	$53.08M	+55.1%
Dec 2006	$34.23M	+107.6%
Sep 2006	$16.49M	-48.4%
May 2005	$31.94M	+7.5%
Feb 2005	$29.72M	-31.2%
Nov 2004	$43.19M	-1.8%
Aug 2004	$43.98M	+5.6%
May 2004	$41.64M	+3.6%
Feb 2004	$40.18M	+9.8%
Nov 2003	$36.58M	+9.7%
Aug 2003	$33.36M	+11.4%
May 2003	$29.94M	-9.6%
Feb 2003	$33.11M	+6.0%
Nov 2002	$31.23M	+1.5%
Aug 2002	$30.77M	+4.2%
May 2002	$29.53M	+17.5%
Feb 2002	$25.12M	+4.2%
Nov 2001	$24.11M	+12.3%
Aug 2001	$21.47M	+5.4%
May 2001	$20.38M	+15.0%
Feb 2001	$17.72M	+12.8%
Nov 2000	$15.70M	+15.9%
Aug 2000	$13.55M	+19.5%
May 2000	$11.34M	+143.1%
Feb 2000	-$26.31M	-78.2%
Nov 1999	-$14.77M	-301.4%
Aug 1999	-$3.68M	-153.5%
May 1999	$6.88M	-87.1%
Feb 1999	$53.30M	+9.7%
Nov 1998	$48.60M	+8.2%
Aug 1998	$44.90M	+6.7%
May 1998	$42.10M	+40.3%
Feb 1998	$30.00M	+50.0%
Nov 1997	$20.00M	+100.0%
Aug 1997	$10.00M	-

FAQ

What is the current TTM EBITDA of ICLR?
As of today, ICLR TTM EBITDA is $1.34B
What is ICLR TTM EBITDA most recent change?
ICLR TTM EBITDA was down -5.85% on March 31, 2026
What is 1-year change in ICLR TTM EBITDA?
ICLR TTM EBITDA is down -18.34% year-over-year
How far is ICLR TTM EBITDA from its all-time high?
ICLR TTM EBITDA is currently -20.61% below its historical high of $1.69B set on March 31, 2024
How does ICLR TTM EBITDA rank versus sector peers?
ICLR TTM EBITDA is higher than 93.74% of companies in Healthcare sector
When is ICLR next earnings release?
The next earnings release for ICLR is on July 23, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

ICLR Official Website www.iconplc.com
ICLR Profile on Yahoo Finance finance.yahoo.com/quote/ICLR
ICLR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iclr